Skip to main content

Loading market data...

IQV

IQVIA Holdings Inc.

NYSE • United states

$275.02

+$7.17

(+2.68%)

Source: Yahoo Finance · Quote time Oct 21, 2026 15:47 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

IQVIA Holdings Inc. (IQV)

Unavailable

Quotes may be delayed

$45.27B

Market Cap

474,788

Volume

32.7

P/E Ratio

Unavailable

Div Yield

IQVIA Holdings Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 2400 ELLIS ROAD, DURHAM, NC
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

23 Sep 2026

IQVIA Holdings Inc. reported A material agreement

IQVIA Holdings Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

9 Sep 2026

IQVIA Holdings Inc. reported Another company event

IQVIA Holdings Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.

28 Jul 2026

IQVIA Holdings Inc. filed Form 10-Q

IQVIA Holdings Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

28 Jul 2026

IQVIA Holdings Inc. reported Operating or financial results

IQVIA Holdings Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

11 Jun 2026

IQVIA Holdings Inc. reported A material agreement

IQVIA Holdings Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.95B

Total assets (USD)$29.68B

Total liabilities (USD)$23.33B

Shareholders' equity (USD)$6.22B

Long-term debt (USD)$13.99B

Debt due within a year (USD)$1.84B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 31 Mar 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q1 2026	$4.15B	$514.00M	$274.00M	$1.61	10-Q · 5 May 2026
Q4 2025	$4.36B	$627.00M	$514.00M	Unavailable	10-K · 17 Feb 2026
Q3 2025	$4.10B	$553.00M	$331.00M	$1.93	10-Q · 28 Oct 2025
Q2 2025	$4.02B	$506.00M	$266.00M	$1.54	10-Q · 22 Jul 2025
Q1 2025	$3.83B	$496.00M	$249.00M	$1.40	10-Q · 6 May 2025
Q4 2024	$3.96B	$626.00M	$437.00M	Unavailable	10-K · 13 Feb 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $299.36

8.9% upside potential

📈

Strong Buy

Unavailable

👍

Buy

13

⏸️

Hold

1

📉

Sell

0

14 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 15:47 UTC Targets range 270.00–345.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

2

Sep 2026

Berkshire James G.

See Remarks

Option exercise

$131.82 per share

5,381 shares

2

Sep 2026

Berkshire James G.

See Remarks

Open-market sale

$261.33 per share

2,668 shares

2

Sep 2026

Berkshire James G.

See Remarks

Disposition to the company

$261.54 per share

2,713 shares

3

Aug 2026

STAUB W RICHARD

See Remarks

Open-market sale

$232.68 per share

5,500 shares

31

Jul 2026

Patel Bhavik

See Remarks

Open-market sale

$235.27 per share

1,855 shares

29

Jul 2026

Sherbet Eric

See Remarks

Open-market sale

$249.16 per share

5,000 shares

29

Jul 2026

Cherofsky Keriann

See Remarks

Open-market sale

$245.21 per share

558 shares

29

Jul 2026

BOUSBIB ARI

Director, See Remarks

Option exercise

$78.21 per share

156,206 shares

29

Jul 2026

BOUSBIB ARI

Director, See Remarks

Open-market sale

$245.51 per share

106,279 shares

29

Jul 2026

BOUSBIB ARI

Director, See Remarks

Disposition to the company

$244.70 per share

49,927 shares

Top Shareholders

Vanguard Group Inc

19,650,532 shares

0.82% change

12/31/2025

Blackrock, Inc.

14,549,693 shares

-3.179% change

6/30/2026

Harris Associates L P

12,183,830 shares

0.005% change

6/30/2026

Vanguard Capital Management Llc

10,905,053 shares

-1.106% change

6/30/2026

State Street Corp

7,508,244 shares

0.418% change

6/30/2026

Vanguard Portfolio Management Llc

7,501,993 shares

-0.977% change

6/30/2026

Jpmorgan Chase & Co

6,139,775 shares

13.538% change

6/30/2026

Artisan Partners Limited Partnership

4,743,434 shares

-6.235% change

6/30/2026

Boston Partners

4,466,016 shares

5.356% change

6/30/2026

Geode Capital Management, Llc

4,454,134 shares

-0.2% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 15:47 UTC· 15 hours ago

Research coverage and investment tools

IQVIA Holdings Inc. (IQV) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch). Its last price was US$275.02 on 21 Oct 2026. That is 98% of the way from its 52-week low of US$154.50 to its 52-week high of US$277.40. Its market capitalisation was US$45.27 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q1 2026	$4.15B	$514.00M	$274.00M	$1.61	—	12.4%	—	10-Q · 5 May 2026 (opens in a new tab)
Q4 2025	$4.36B	$627.00M	$514.00M	Unavailable	—	14.4%	—	10-K · 17 Feb 2026 (opens in a new tab)
Q3 2025	$4.10B	$553.00M	$331.00M	$1.93	—	13.5%	—	10-Q · 28 Oct 2025 (opens in a new tab)
Q2 2025	$4.02B	$506.00M	$266.00M	$1.54	—	12.6%	—	10-Q · 22 Jul 2025 (opens in a new tab)
Q1 2025	$3.83B	$496.00M	$249.00M	$1.40	—	13.0%	—	10-Q · 6 May 2025 (opens in a new tab)
Q4 2024	$3.96B	$626.00M	$437.00M	Unavailable	—	15.8%	—	10-K · 13 Feb 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/28/2026	$2.75	$2.72	+1.1%
Mar 2026	5/5/2026	$2.64	$2.51	+5.2%
Dec 2025	2/5/2026	$3.24	$3.13	+3.5%
Sep 2025	10/28/2025	$2.73	$2.68	+1.9%

Cash and equivalents: $1.95B
Total assets: $29.68B
Total liabilities: $23.33B
Shareholders' equity: $6.22B
Long-term debt: $13.99B
Debt due within a year: $1.84B

8-K · 23 Sep 2026 · Material agreement Signed

IQVIA Holdings Inc. reported A material agreement (opens in a new tab)

IQVIA Holdings Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.
8-K · 9 Sep 2026

IQVIA Holdings Inc. reported Another company event (opens in a new tab)

IQVIA Holdings Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.
10-Q · 28 Jul 2026

IQVIA Holdings Inc. filed Form 10-Q (opens in a new tab)

IQVIA Holdings Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 28 Jul 2026

IQVIA Holdings Inc. reported Operating or financial results (opens in a new tab)

IQVIA Holdings Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 11 Jun 2026 · Material agreement Signed

IQVIA Holdings Inc. reported A material agreement (opens in a new tab)

IQVIA Holdings Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Berkshire James G. See Remarks	2 Sep 2026	Option exercise (M)	+5,381	$131.82	Form 4 (opens in a new tab)
Berkshire James G. See Remarks	2 Sep 2026	Open-market sale (S)	−2,668	$261.33	Form 4 (opens in a new tab)
Berkshire James G. See Remarks	2 Sep 2026	Disposition to the company (D)	−2,713	$261.54	Form 4 (opens in a new tab)
STAUB W RICHARD See Remarks	3 Aug 2026	Open-market sale (S)	−5,500	$232.68	Form 4 (opens in a new tab)
Patel Bhavik See Remarks	31 Jul 2026	Open-market sale (S)	−1,855	$235.27	Form 4 (opens in a new tab)
Sherbet Eric See Remarks	29 Jul 2026	Open-market sale (S)	−5,000	$249.16	Form 4 (opens in a new tab)
Cherofsky Keriann See Remarks	29 Jul 2026	Open-market sale (S)	−558	$245.21	Form 4 (opens in a new tab)
BOUSBIB ARI Director, See Remarks	29 Jul 2026	Option exercise (M)	+156,206	$78.21	Form 4 (opens in a new tab)
BOUSBIB ARI Director, See Remarks	29 Jul 2026	Open-market sale (S)	−106,279	$245.51	Form 4 (opens in a new tab)
BOUSBIB ARI Director, See Remarks	29 Jul 2026	Disposition to the company (D)	−49,927	$244.70	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	19,650,532	0.82%
Blackrock, Inc.	6/30/2026	14,549,693	-3.179%
Harris Associates L P	6/30/2026	12,183,830	0.005%
Vanguard Capital Management Llc	6/30/2026	10,905,053	-1.106%
State Street Corp	6/30/2026	7,508,244	0.418%
Vanguard Portfolio Management Llc	6/30/2026	7,501,993	-0.977%
Jpmorgan Chase & Co	6/30/2026	6,139,775	13.538%
Artisan Partners Limited Partnership	6/30/2026	4,743,434	-6.235%
Boston Partners	6/30/2026	4,466,016	5.356%
Geode Capital Management, Llc	6/30/2026	4,454,134	-0.2%

Previous close: 267.85 USD
Day range: 263.97 – 275.04 USD
52-week range: 154.50 – 277.40 USD
Volume: 474,788
Market cap: $45.27B
Average volume: 1,052,592
P/E ratio: 32.7
EPS (FY 2025, diluted): 7.84 USD
Shares outstanding: 164.60M
Beta (5Y monthly): 1.17

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 15:47 UTC· 15 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:28 UTC· 46 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for IQV yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.